These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21768575)

  • 1. ACP Journal Club. Review: Dopamine agonists are effective for the restless legs syndrome but may be discontinued due to adverse events.
    Andolsek KM
    Ann Intern Med; 2011 Jul; 155(2):JC1-9. PubMed ID: 21768575
    [No Abstract]   [Full Text] [Related]  

  • 2. Review: nonergot dopamine agonists reduce symptoms in the restless legs syndrome but may be discontinued due to adverse events.
    Kaushik S; Blanchard AR
    ACP J Club; 2008; 149(4):10. PubMed ID: 18937388
    [No Abstract]   [Full Text] [Related]  

  • 3. Restless legs syndrome.
    Bayard M; Avonda T; Wadzinski J
    Am Fam Physician; 2008 Jul; 78(2):235-40. PubMed ID: 18697508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ropinirole in the treatment of restless legs syndrome.
    Kakar RS; Kushida CA
    Expert Rev Neurother; 2005 Jan; 5(1):35-42. PubMed ID: 15853472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of restless legs syndrome with dopamine agonists.
    Ondo W; Romanyshyn J; Vuong KD; Lai D
    Arch Neurol; 2004 Sep; 61(9):1393-7. PubMed ID: 15364685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ropinirole: new indication. Restless legs: disproportionate adverse effects.
    Prescrire Int; 2006 Oct; 15(85):173-6. PubMed ID: 17128523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Restless legs].
    Kinge E; Lossius MI
    Tidsskr Nor Laegeforen; 2004 Jan; 124(1):25-7. PubMed ID: 14716387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR).
    Oertel WH; Benes H; Bodenschatz R; Peglau I; Warmuth R; Happe S; Geisler P; Cassel W; Leroux M; Kohnen R; Stiasny-Kolster K
    Neurology; 2006 Sep; 67(6):1040-6. PubMed ID: 16931508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.
    Walters AS; Ondo WG; Dreykluft T; Grunstein R; Lee D; Sethi K;
    Mov Disord; 2004 Dec; 19(12):1414-23. PubMed ID: 15390050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of pramipexole in chinese patients with restless legs syndrome: results from a multi-center, randomized, double-blind, placebo-controlled trial.
    Ma JF; Wan Q; Hu XY; Sun SG; Wang WZ; Zhao ZX; Wang YJ; Liu CF; Li JM; Jiang YP; Chen SD
    Sleep Med; 2012 Jan; 13(1):58-63. PubMed ID: 22137119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term open-label study of pramipexole in patients with primary restless legs syndrome.
    Inoue Y; Kuroda K; Hirata K; Uchimura N; Kagimura T; Shimizu T
    J Neurol Sci; 2010 Jul; 294(1-2):62-6. PubMed ID: 20451927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Restless legs syndrome].
    Lai SC; Chen RS
    Acta Neurol Taiwan; 2008 Mar; 17(1):54-65. PubMed ID: 18564830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine and the spinal cord in restless legs syndrome: does spinal cord physiology reveal a basis for augmentation?
    Paulus W; Schomburg ED
    Sleep Med Rev; 2006 Jun; 10(3):185-96. PubMed ID: 16762808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emergence of devastating impulse control disorders during dopamine agonist therapy of the restless legs syndrome.
    Dang D; Cunnington D; Swieca J
    Clin Neuropharmacol; 2011; 34(2):66-70. PubMed ID: 21412200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists.
    Tippmann-Peikert M; Park JG; Boeve BF; Shepard JW; Silber MH
    Neurology; 2007 Jan; 68(4):301-3. PubMed ID: 17242339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of ropinirol ++ as a treatment for restless leg syndrome].
    Estivill E; de la Fuente V
    Rev Neurol; 1999 May 16-31; 28(10):962-3. PubMed ID: 10416230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Restless legs syndrome: therapeutic possibilities in the medical practice].
    Bachmann CG; Trenkwalder C
    MMW Fortschr Med; 2005 May; 147 Spec No 2():44-7. PubMed ID: 15968872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial.
    Montplaisir J; Karrasch J; Haan J; Volc D
    Mov Disord; 2006 Oct; 21(10):1627-35. PubMed ID: 16874755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Restless legs syndrome and depression].
    Rasmussen J; Videbech P
    Ugeskr Laeger; 2011 Aug; 173(35):2113-7. PubMed ID: 21884661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological gambling associated with dopamine agonist use in restless legs syndrome.
    Quickfall J; Suchowersky O
    Parkinsonism Relat Disord; 2007 Dec; 13(8):535-6. PubMed ID: 17270485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.